Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study

NCT05612204 is registered in ClinicalTrials.gov with GCS Ramsay Santé pour l'Enseignement et la Recherche as lead sponsor.

NCT NCT05612204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05612204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Not applicable
Overall status
Completed
Start date
November 21, 2022
Completion date
June 30, 2024
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer